From Trump’s Project 2025 to a huge aid cut by the Dutch, donors are turning their backs on the developing world

Foreign aid spending reached a record high of $223bn (£180bn) in 2023, new figures released this week from the Organisation for Economic Co-operation and Development (OECD) confirmed.

Yet, in 2024, eight wealthy countries announced $17.2bn in cuts to official development assistance (ODA), and three others hinted at reductions, all to take effect over the next five years.

Pharmaceutical corporations claim high prices are the cost of innovation, but the reality is far more complicated — and troubling. In 2030, the patents of some of the world’s best-selling drugs will expire, an event called the 'patent cliff', and companies are doubling down on tactics such as 'evergreening' patents and pay-for-delay deals to keep prices high and competition out.

In this video, Neelam Tailor uncovers the shocking strategies big pharma use to game the system, explaining how these moves protect profits but hurt patients